74 filings
Page 2 of 4
8-K
nvkxqpot7p3xmr3
28 Mar 23
MaxCyte Appoints Douglas Swirsky as Chief Financial Officer
9:40am
8-K
z8dp9ofn2o
15 Mar 23
MaxCyte Reports Fourth Quarter and Full Year 2022 Financial Results
4:15pm
8-K
v6n0ifgwjqpkyj7
6 Mar 23
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Revenue Results and Provides 2023 Revenue Guidance
5:04pm
8-K
0ucb5p 3w
1 Dec 22
MaxCyte Appoints Patrick J. Balthrop as Non-Executive Director
8:30am
8-K
mnx3qpbka8w8
9 Nov 22
MaxCyte Reports Third Quarter 2022 Financial Results
4:15pm
8-K
kc66ix4un64cx35dh4
10 Aug 22
MaxCyte Reports Second Quarter and Half-Year 2022 Financial Results
4:15pm
S-8
gx9ehs
14 Jul 22
Registration of securities for employees
4:37pm
8-K
yw9b3pg
30 Jun 22
Departure of Directors or Certain Officers
4:44pm
8-K
rm79dkuff srv2
9 May 22
MaxCyte Reports First Quarter Financial Results
12:00am
8-K
hyhpxvd3sab8
12 Apr 22
MaxCyte Announces Departure of CFO and Appointment of Ron Holtz as Interim CFO, Announces Preliminary First Quarter 2022 Revenue
4:26pm
10-K
sd4zal3l
22 Mar 22
Annual report
5:16pm
8-K
r6vyd0ob 7kwney
22 Mar 22
MaxCyte Reports Fourth Quarter and Full Year Financial Results
4:15pm
8-K
1r3m7
24 Jan 22
MaxCyte Announces Strong Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue Results
5:05pm